Table 3.
Sectoral epithelial thickness at each time point before and after ATE-CXL (mean±SD)
| Epithelialthicknesses (μm) | Preoperation | Postoperation | ||
| 6 months | 12 months | 36 months | ||
| Mininum | 42.10±7.18 | 42.55±6.46 | 41.65±8.50 | 43.44±7.52 |
| Centre | 51.23±5.34 | 51.98±5.60 | 52.53±6.16 | 51.73±5.84 |
| Paracentral-S | 56.27±5.39 | 56.45±7.06 | 57.50±7.25 | 58.22±5.09 |
| Paracentral-SN | 57.85±5.93 | 56.85±6.28 | 58.50±6.41 | 58.88±4.93 |
| Paracentral-N | 58.00±5.20 | 57.45±5.37 | 58.56±6.18 | 57.76±4.81 |
| Paracentral-IN | 56.90±4.83 | 54.98±9.94 | 55.62±4.86 | 56.20±6.33 |
| Paracentral-I | 53.88±6.69 | 53.05±7.22 | 51.68±6.88 | 54.00±6.36 |
| Paracentral-IT | 50.31±5.47 | 49.55±6.61 | 48.29±6.37 | 50.76±6.32 |
| Paracentral-T | 50.92±6.17 | 51.90±6.21 | 52.44±7.57 | 52.17±6.73 |
| Paracentral-ST | 55.83±6.10 | 57.15±7.67 | 57.71±7.82 | 57.05±7.17 |
| Mid-peripheral-S | 53.40±6.14 | 53.88±6.37 | 54.82±7.71 | 56.29±5.69 * |
| Mid-peripheral-SN | 56.10±5.13 | 55.25±5.48 | 56.12±5.90 | 57.73±4.70 |
| Mid-peripheral-N | 59.46±4.90 | 58.03±4.31 | 58.32±4.92 | 59.56±4.83 |
| Mid-peripheral-IN | 60.38±4.54 | 59.80±5.28 | 58.62±4.47 | 60.22±5.85 |
| Mid-peripheral-I | 58.15±7.41 | 57.25±8.21 | 55.97±7.40 | 59.66±6.24 |
| Mid-peripheral-IT | 55.27±7.09 | 53.70±7.74 | 52.62±7.84 | 55.80±6.16 |
| Mid-peripheral-T | 55.38±6.51 | 56.33±5.42 | 56.24±6.38 | 56.07±5.43 |
| Mid-peripheral-ST | 56.77±6.41 | 57.60±5.52 | 57.56±5.66 | 58.34±5.29 |
*A significant difference was detected.
ATE-CXL, accelerated transepithelial corneal cross-linking; I, inferior; N, nasal; S, superior; T, temporal.